Lucyd, Inc

US$0.82As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:LUCYHealthcare
Country USA
PE (Fwd) •••
TSR 4Y CAGR (64.15%)
Div yield —
ROE (84.58%)
Medical Instruments & Supplies
Beta (5Y) 2.74
PE TTM —
TSR TTM (52.31%)
Mkt cap US$7.188M
ROIC (58.43%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.05
27.43%
9.14%
Hold 12|12|2|6|7
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
2.33%
(2.98%)
1.23%
3.74%
Revenue$M
0.668
0.664
0.685
0.709
17.03%
10.75%
9.63%
11.33%
Peers (US$7.188M)
Cap (US$)
PE
11.47M
—
6.817M
—
Capital
TTM
5Y
10Y
Leveragex
0.883
0.027
0.024
EBIT/Intx
0.945
0.126
0.105
Own earn%
141.76
19.11
24.97
Sh yield%
38.69
32.81
32.73
Owners
Insiders/Inst%
9.24
29.41
Short interest%
3.54
SBC / revenue%
5.73
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
31–35
$1 testx
−0.2
Incr. ROIC%
39